Already inside the gate: the company is specified into someone else's next wave, and the wave has not yet shipped
The model's full reasoning — Q3 2018 call → NOWe need answer only YES or NO. Need analyze transcript. Need determine if management describes company already chosen/specified/qualified inside another organization's future product/program/platform/build-out/standard plan, wave not yet arrived, position large, preparing. We need use only transcript. Let's parse. Company Agios. Products TIBSOVO, IDHIFA, mitapivat, AG-270, AG-636, AG-881. Need see if any relationship with another org's future product/program where Agios already locked in and wave ahead. Potential: Celgene partnership? They gained worldwide rights to AG-881 from Celgene. Not about being inside Celgene's future product. IDHIFA is partnered with Celgene? Actually IDHIFA (enasidenib) is partnered with Celgene? Agios has collaboration with Celgene for IDH inhibitors? In transcript: "IDHIFA won Prix Galien" and royalty. They mention "IDHIFA royalty" increased. But not about being chosen inside Celgene's next thing. TIBSOVO launch: own product, not inside another org's future product. No. Mitapivat pivotal trials in PK deficiency: own program. No. AG-270, AG-636: own. Maybe "HOVON 150, a Phase 3 trial sponsored by European Cooperative Groups, combining both IDH inhibitors with 7-plus-3 remains on track to initiate this quarter." This is Agios's drug being used in a trial sponsored by cooperative group. Is that "already been chosen, specified, qualified, designed in" inside another organization's future program? The cooperative group's trial is a program, but Agios's drug is being tested. However, is Agios already locked in? The trial is sponsored by European Cooperative Groups, and Agios's drugs are included. But this is a clinical trial, not a commercial product. The question asks "another organization's future product, program, platform, build-out, or standard operating plan" and "when that outside party's own next wave of activity arrives, this company's volume arrives with it automatically." Clinical trial doesn't generate volume/revenue automatically; it's a study. Also not "secured position" for commercial sales. No. Maybe "FDA has accepted our application into Real-Time Oncology Review Pilot Program" - not another org's future product. Maybe "we plan to submit sNDA for TIBSOVO in newly diagnosed AML" - regulatory approval, not another org's product. Maybe "we gained worldwide rights to AG-881 from Celgene" - no.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| NC | NACCO Industries, Inc. | Q1 2024 | 2024-05-05 | C+ |
| CLGN | CollPlant Biotechnologies Ltd. | Q4 2023 | 2024-04-04 | F |
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| AIRG | Airgain, Inc. | Q3 2023 | 2023-11-09 | F |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| CUBI | Customers Bancorp, Inc. | Q3 2018 | 2018-10-26 | C+ |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
| THRM | Gentherm Incorporated | Q2 2016 | 2016-07-28 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| SPR | Spirit AeroSystems Holdings, Inc. | Q1 2016 | 2016-04-29 | D |
CUBI · Q3 2018 → YESThe question is about whether management describes that the company has already been chosen or locked into another organization's future product/program, such that volume will come automatically when ...NO The transcript describes a white-label partnership with T-Mobile where BankMobile provides services under T-Mobile's brand, with deposits expected to start in the next year after the launch. However, this does not meet the criteria for a secured position inside T-Mobile's next product or program. The language focuses on a partnership relationship that is still being launched, rather than a design win or qualification already embedded in T-Mobile's future offering. Management refers to it as an "expected white label partnership" and "working on" the launch, indicating it is not yet locked in as part of T-Mobile's committed plan.
EMKR · Q4 2023 → YESThe question is about whether management describes that the company has already been chosen or locked into another organization's future product/program, such that volume will come automatically when ...NO The transcript describes an agreement with Kratos for Inertial Navigation Systems to be included in the XQ58 Valkyrie drone, with the Air Force planning to acquire at least 1,000 units. However, this is framed as an announcement of a new agreement rather than a secured, locked-in position already designed 100% into the platform with volume guaranteed.
NC · Q1 2024 → YESThe question is about whether management describes that the company has already been chosen or locked into another organization's future product/program, such that volume will arrive automatically whe...